In current European and American revascularization guidelines, RA grafts are now strongly endorsed as the second conduit for ...

Researchers report a discovery in cardiac regeneration that offers new hope for the treatment of ischemic heart failure. Published in npj Regenerative Medicine, the study reveals a novel approach to ...

Calcium channel blockers are a group of medications that act to inhibit either central or peripheral calcium channels. This results in decreased calcium influx and smooth muscle relaxation.

A recent study has raised concerns about a widely used blood pressure medication called Calcium Channel Blockers (CCBs).

To manage high blood pressure, doctors usually recommend lifestyle changes and prescribe medications. Among the most common ...

The Calcium Channel Blockers Market was valued at US$ 14.5 Bn in 2022 and is projected to grow at a CAGR of 5.7% from 2023 to ...

which enables the calcium channel to open at relatively hyperpolarized potentials. 8 This calcium-mediated pacemaking capability, however, comes at a metabolic cost for the dopaminergic neurons.

The drugs most frequently used by these patients were diuretics, converting enzyme inhibitors, calcium channel blockers (CCB), lipid-lowering agents, and salicylates. Eczema was significantly ...

The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure.

Researchers in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane, Australia, and collaborating institutions report a ...